Director and Professor, Ming-Wai Lau Center for Reparative Medicine @ (January 2016 - July 2020)
Chief Executive Officer and Interim Research and Development Officer @ Novoheart (January 2016 - Present)
Professor, Dr Li Dak-Sum Research Center, Hku-Ki Collaboration in Regenerative Medicine @ (January 2016 - Present)
Director, Stem Cell and Regenerative Medicine Consortium @ (January 2010 - January 2015)
Co-Director, Section of Cardiovascular Cell and Tissue Engineering, Cardiovascular Research Center @ (January 2009 - January 2015)
Director, Human Embryonic Stem Cell Consortium @ (November 2005 - December 2009)
Associate Investigator, Institute of Pediatric Regenerative Medicine @ (June 2006 - November 2009)
Adjunct Associate Professor, Division of Cardiology, Department of Medicine @ (November 2005 - November 2009)
Assistant Professor, Cellular and Molecular Medicine @ (September 2003 - October 2005)
Assistant Professor of Medicine @ (January 2002 - October 2005)
Research Assistant Professor @ (July 2001 - December 2001)
Ronald Li Education
The Johns Hopkins University School of Medicine 1998-2001
University of Toronto
Doctor of Philosophy (Physiology, Philosophy)
1995-1998
University of Waterloo
Bachelor of Science (Biotechnology, Biochemistry)
1990-1994
Diocesan Boys School, Hong Kong 1983-1989
Ronald Li Skills
Biotechnology
Cell Biology
Leadership
Management
Stem Cells
Tissue Engineering
Ronald Li Summary
Ronald Li, based in Boston, MA, US, is currently a Chief Executive Officer at Medera Biopharmaceutical. Ronald Li brings experience from previous roles at Sardocor Therapeutics, Karolinska Institutet, Novoheart and The University of Hong Kong. Ronald Li holds a 1998 - 2001 The Johns Hopkins University School of Medicine. With a robust skill set that includes Biotechnology, Cell Biology, Leadership, Management, Stem Cells and more. Ronald Li has 1 emails on RocketReach.
Looking for a different Ronald Li?
Find contact details for 700 million professionals.